ROIV filings
Corporate insider profile
Matthew Gline Filing Activity
Latest reported as CEO of Roivant Sciences Ltd. (ROIV).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$8,449,809.84
- Latest transaction
- Apr 16, 2026
Transaction history
